Natixis Investment Managers International cut its stake in shares of Chemed Co. (NYSE:CHE – Free Report) by 26.6% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 30,080 shares of the company’s stock after selling 10,890 shares during the period. Natixis Investment […]
Epoch Investment Partners Inc. raised its holdings in shares of Chemed Co. (NYSE:CHE – Free Report) by 85.2% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 152,162 shares of the company’s stock after purchasing an additional 70,001 shares during the […]
Chemed Corporation today announced that it will deliver a presentation at the Jefferies 2024 Global Healthcare Conference on Wednesday, June 5, 2024, at approximately 9:00 a.m. at the New York.
AXS Investments LLC purchased a new position in Chemed Co. (NYSE:CHE – Free Report) in the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund purchased 310 shares of the company’s stock, valued at approximately $181,000. Other large investors have also recently modified their holdings of the company. […]
Chemed (NYSE:CHE – Free Report) had its price target cut by Royal Bank of Canada from $712.00 to $697.00 in a research report released on Tuesday morning, Benzinga reports. They currently have an outperform rating on the stock. Several other brokerages have also recently issued reports on CHE. Oppenheimer boosted their price target on Chemed […]